Discontinuation of statin therapy and clinical outcome after non-ST-elevation acute coronary syndrome

被引：0
|
作者：
Colivicchi, F. [1 ]
Tubaro, M. [1 ]
Mocini, D. [1 ]
Macchiusi, A. [1 ]
Pandozi, A. [1 ]
Santini, M. [1 ]
机构：
[1] San Filippo Neri Hosp, Rome, Italy
来源：
EUROPEAN HEART JOURNAL | 2008年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [21] Correlation of Risk Scores with Coronary Anatomy in Non-ST-elevation Acute Coronary Syndrome
    dos Santos, Elizabete Silva
    Aguiar Filho, Luciano de Figueiredo
    Fonseca, Daniela Menezes
    Londero, Hugo Jose
    Xavier, Rogerio Martins
    Pereira, Marcos Paulo
    Minuzzo, Luiz
    de Souza, Roberta
    Timerman, Ari
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 100 (06) : 511 - 517
  • [22] Platelet inhibition after loading dose of prasugrel in patients with ST-elevation and non-ST-elevation acute coronary syndrome
    Wakabayashi S.
    Kitahara H.
    Nishi T.
    Sugimoto K.
    Nakayama T.
    Fujimoto Y.
    Ariyoshi N.
    Kobayashi Y.
    Cardiovascular Intervention and Therapeutics, 2018, 33 (3) : 239 - 246
  • [23] Acute massive pulmonary embolism mimicking non-ST-elevation acute coronary syndrome
    Panduranga, Prashanth
    El-Deeb, Mohammed
    EGYPTIAN HEART JOURNAL, 2013, 65 (03): : 239 - 242
  • [24] WAIST-HIP-RATIO AND 1-YEAR CLINICAL OUTCOME IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME
    Lee, H. W.
    Hong, T. J.
    Choi, J. H.
    Kim, B. W.
    ATHEROSCLEROSIS, 2016, 252 : E12 - E13
  • [25] Management of older patients presenting with non-ST-elevation acute coronary syndrome
    Chan, Danny
    Lawson, Lucy
    Kunadian, Vijay
    EUROINTERVENTION, 2018, 14 (03) : 258 - 260
  • [26] Prognostic role of plasma angiogenin in non-ST-elevation acute coronary syndrome
    Tello-Montoliu, A.
    Marin, F.
    Patel, J.
    Mainar, L.
    Roldan, V.
    Chung, I.
    Choudhury, A.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2006, 27 : 222 - 222
  • [27] Economic evaluation of the use of enoxaparin in non-ST-elevation acute coronary syndrome
    Nutescu, Edith A.
    Peter, Karen Steinmetz
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (01) : 95 - 105
  • [28] Markers of hemostasis activation after early discontinuation of fondaparinux in low-risk patients hospitalized with non-ST-elevation acute coronary syndrome
    Yavelov, I. S.
    Knyazev, A. S.
    Dobrovolsky, A. B.
    Gratsiansky, N. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 533 - 533
  • [29] ESC guidelines 2015. Non-ST-elevation acute coronary syndrome
    Jobs, A.
    Thiele, H.
    HERZ, 2015, 40 (08) : 1027 - 1033
  • [30] Copeptin for the prediction of adverse events in non-ST-elevation acute coronary syndrome
    Morawiec, B.
    Kawecki, D.
    Przywara-Chowaniec, B.
    Opara, M.
    Gabrysiak, A.
    Szymanski, R.
    Ho, L. A. M.
    Muller, O.
    Nowalany-Kozielska, E.
    EUROPEAN HEART JOURNAL, 2015, 36 : 7 - 7
12345